Treatment resistant M-type phospholipase A2 receptor associated membranous nephropathy responds to obinutuzumab: a report of two cases

BACKGROUND: Membranous Nephropathy (MN) is a common cause of nephrotic syndrome (NS) in adults. Recognition of MN as an antibody mediated autoimmune disease has enabled the introduction of anti-B-cell therapy. Rituximab, a type I anti-CD20 antibody has been used in the management of MN, but has a 35...

Descripción completa

Detalles Bibliográficos
Autores principales: Hudson, Rebecca, Rawlings, Cassandra, Mon, Saw Yu, Jefferis, Julia, John, George T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991934/
https://www.ncbi.nlm.nih.gov/pubmed/35392837
http://dx.doi.org/10.1186/s12882-022-02761-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991934/
https://www.ncbi.nlm.nih.gov/pubmed/35392837
http://dx.doi.org/10.1186/s12882-022-02761-3

Ejemplares similares